Advertisement
Screener

ELEVANCE HEALTH, INC. (ELV) Cash and Cash Equivalents, Period Increase (Decrease)

2.8 / 5 stars · 66/120 Roast Me

ELEVANCE HEALTH, INC. Cash and Cash Equivalents, Period Increase (Decrease)

ELEVANCE HEALTH, INC. (ELV) reported Cash and Cash Equivalents, Period Increase (Decrease) of $1.00 billion for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-19.

Discontinued › Cash Flow › Change in Cash

us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2020-02-19

  • ELEVANCE HEALTH, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-12-31 was $747.00M.
  • ELEVANCE HEALTH, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-09-30 was $112.00M.
  • ELEVANCE HEALTH, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was -$404.00M, a 892.16% decline year-over-year.
  • ELEVANCE HEALTH, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was $548.00M, a 46.38% decline year-over-year.
  • ELEVANCE HEALTH, INC. cash and cash equivalents, period increase (decrease) for fiscal 2019 was $1.00B, a 208.62% increase from fiscal 2018.
  • ELEVANCE HEALTH, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $325.00M.
  • ELEVANCE HEALTH, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$466.00M, a 123.75% decline from fiscal 2016.
  • ELEVANCE HEALTH, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $1.96B.
Period endCash and Cash Equivalents, Period Increase (Decrease) 3 monthCash and Cash Equivalents, Period Increase (Decrease) 3 month as first filedCash and Cash Equivalents, Period Increase (Decrease) 6 monthCash and Cash Equivalents, Period Increase (Decrease) 6 month as first filedCash and Cash Equivalents, Period Increase (Decrease) 9 monthCash and Cash Equivalents, Period Increase (Decrease) 9 month as first filedCash and Cash Equivalents, Period Increase (Decrease) 12 monthCash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed
2019-12-31$747.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19
$859.00M
derived: sum of 2 quarters · filed 2020-02-19
$455.00M
derived: sum of 3 quarters · filed 2020-02-19
$1.00B
10-K · filed 2020-02-19
2019-09-30$112.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-23
-$292.00M
derived: sum of 2 quarters · filed 2019-10-23
$256.00M
10-Q · filed 2019-10-23
-$70.00M
derived: sum of 4 quarters · filed 2020-02-19
2019-06-30-$404.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24
$144.00M
10-Q · filed 2019-07-24
-$182.00M
derived: sum of 3 quarters · filed 2020-02-19
-$604.00M
derived: sum of 4 quarters · filed 2020-02-19
2019-03-31$548.00M
10-Q · filed 2019-04-24
$222.00M
derived: sum of 2 quarters · filed 2020-02-19
-$200.00M
derived: sum of 3 quarters · filed 2020-02-19
-$149.00M
derived: sum of 4 quarters · filed 2020-02-19
2018-12-31-$326.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19
-$748.00M
derived: sum of 2 quarters · filed 2020-02-19
-$697.00M
derived: sum of 3 quarters · filed 2020-02-19
$325.00M
10-K · filed 2020-02-19
2018-09-30-$422.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-23
-$371.00M
derived: sum of 2 quarters · filed 2019-10-23
$651.00M
10-Q · filed 2019-10-23
-$1.84B
derived: sum of 4 quarters · filed 2020-02-19
2018-06-30$51.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24
$1.07B
10-Q · filed 2019-07-24
$1.07B
10-Q · filed 2018-07-25
-$1.42B
derived: sum of 3 quarters · filed 2020-02-19
$121.10M
derived: sum of 4 quarters · filed 2020-02-19
2018-03-31$1.02B
10-Q · filed 2019-04-24
$1.02B
10-Q · filed 2018-04-25
-$1.47B
derived: sum of 2 quarters · filed 2020-02-19
$70.10M
derived: sum of 3 quarters · filed 2020-02-19
-$2.14B
derived: sum of 4 quarters · filed 2020-02-19
2017-12-31-$2.49B
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19
-$951.90M
derived: sum of 2 quarters · filed 2020-02-19
-$3.16B
derived: sum of 3 quarters · filed 2020-02-19
-$466.00M
10-K · filed 2020-02-19
-$466.40M
10-K · filed 2018-02-21
2017-09-30$1.54B
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31
-$675.10M
derived: sum of 2 quarters · filed 2018-10-31
$2.02B
10-Q · filed 2018-10-31
$2.02B
10-Q · filed 2017-10-25
$3.55B
derived: sum of 4 quarters · filed 2019-02-20
2017-06-30-$2.21B
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-25
$485.90M
10-Q · filed 2018-07-25
$2.02B
derived: sum of 3 quarters · filed 2019-02-20
$2.98B
derived: sum of 4 quarters · filed 2019-02-20
2017-03-31$2.70B
10-Q · filed 2018-04-25
$4.23B
derived: sum of 2 quarters · filed 2019-02-20
$5.19B
derived: sum of 3 quarters · filed 2019-02-20
$5.10B
derived: sum of 4 quarters · filed 2019-02-20
2016-12-31$1.53B
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20
$2.49B
derived: sum of 2 quarters · filed 2019-02-20
$2.40B
derived: sum of 3 quarters · filed 2019-02-20
$1.96B
10-K · filed 2019-02-20
$1.96B
10-K · filed 2017-02-22
2016-09-30$963.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-25
$870.00M
derived: sum of 2 quarters · filed 2017-10-25
$432.50M
10-Q · filed 2017-10-25
$998.20M
derived: sum of 4 quarters · filed 2018-02-21
2016-06-30-$93.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26
-$530.80M
10-Q · filed 2017-07-26
$34.90M
derived: sum of 3 quarters · filed 2018-02-21
$29.70M
derived: sum of 4 quarters · filed 2018-02-21
2016-03-31-$437.50M
10-Q · filed 2017-04-26
$128.20M
derived: sum of 2 quarters · filed 2018-02-21
$123.00M
derived: sum of 3 quarters · filed 2018-02-21
$279.00M
derived: sum of 4 quarters · filed 2018-02-21
2015-12-31$565.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21
$560.50M
derived: sum of 2 quarters · filed 2018-02-21
$716.50M
derived: sum of 3 quarters · filed 2018-02-21
-$38.20M
10-K · filed 2018-02-21
2015-09-30-$5.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02
$150.80M
derived: sum of 2 quarters · filed 2016-11-02
-$603.90M
10-Q · filed 2016-11-02
-$170.10M
derived: sum of 4 quarters · filed 2017-02-22
2015-06-30$156.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-27
-$598.70M
10-Q · filed 2016-07-27
-$164.90M
derived: sum of 3 quarters · filed 2017-02-22
-$231.60M
derived: sum of 4 quarters · filed 2017-02-22
2015-03-31-$754.70M
10-Q · filed 2016-04-27
-$320.90M
derived: sum of 2 quarters · filed 2017-02-22
-$387.60M
derived: sum of 3 quarters · filed 2017-02-22
-$574.20M
derived: sum of 4 quarters · filed 2017-02-22
2014-12-31$433.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22
$367.10M
derived: sum of 2 quarters · filed 2017-02-22
$180.50M
derived: sum of 3 quarters · filed 2017-02-22
$564.80M
10-K · filed 2017-02-22
2014-09-30-$66.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-28
-$253.30M
derived: sum of 2 quarters · filed 2015-10-28
$131.00M
10-Q · filed 2015-10-28
-$467.80M
derived: sum of 4 quarters · filed 2016-02-19
2014-06-30-$186.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29
$197.70M
10-Q · filed 2015-07-29
-$401.10M
derived: sum of 3 quarters · filed 2016-02-19
$437.30M
derived: sum of 4 quarters · filed 2016-02-19
2014-03-31$384.30M
10-Q · filed 2015-04-29
-$214.50M
derived: sum of 2 quarters · filed 2016-02-19
$623.90M
derived: sum of 3 quarters · filed 2016-02-19
$305.90M
derived: sum of 4 quarters · filed 2016-02-19
2013-12-31-$598.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19
$239.60M
derived: sum of 2 quarters · filed 2016-02-19
-$78.40M
derived: sum of 3 quarters · filed 2016-02-19
-$897.70M
10-K · filed 2016-02-19
2013-09-30$838.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29
$520.40M
derived: sum of 2 quarters · filed 2014-10-29
-$298.90M
10-Q · filed 2014-10-29
-$256.40M
derived: sum of 4 quarters · filed 2015-02-24
2013-06-30-$318.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-30
-$1.14B
10-Q · filed 2013-07-24
-$1.09B
derived: sum of 3 quarters · filed 2015-02-24
-$605.80M
derived: sum of 4 quarters · filed 2015-02-24
2013-03-31-$819.30M
10-Q · filed 2014-04-30
-$776.80M
derived: sum of 2 quarters · filed 2015-02-24
-$287.80M
derived: sum of 3 quarters · filed 2015-02-24
-$613.80M
derived: sum of 4 quarters · filed 2015-02-24
2012-12-31$42.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24
$531.50M
derived: sum of 2 quarters · filed 2015-02-24
$205.50M
derived: sum of 3 quarters · filed 2015-02-24
$283.00M
10-K · filed 2015-02-24
2012-09-30$489.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23
$163.00M
derived: sum of 2 quarters · filed 2013-10-23
$240.50M
10-Q · filed 2013-10-23
-$66.30M
derived: sum of 4 quarters · filed 2014-02-20
2012-06-30-$326.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-24
-$248.50M
10-Q · filed 2013-07-24
-$555.30M
derived: sum of 3 quarters · filed 2014-02-20
$253.30M
derived: sum of 4 quarters · filed 2014-02-20
2012-03-31$77.50M
10-Q · filed 2013-04-24
-$229.30M
derived: sum of 2 quarters · filed 2014-02-20
$579.30M
derived: sum of 3 quarters · filed 2014-02-20
-$122.90M
derived: sum of 4 quarters · filed 2014-02-20
2011-12-31-$306.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20
$501.80M
derived: sum of 2 quarters · filed 2014-02-20
-$200.40M
derived: sum of 3 quarters · filed 2014-02-20
$412.80M
10-K · filed 2014-02-20
2011-09-30$808.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07
$106.40M
derived: sum of 2 quarters · filed 2012-11-07
$719.60M
10-Q · filed 2012-11-07
$262.20M
derived: sum of 4 quarters · filed 2013-02-22
2011-06-30-$702.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-25
-$89.00M
10-Q · filed 2012-07-25
-$546.40M
derived: sum of 3 quarters · filed 2013-02-22
-$328.10M
derived: sum of 4 quarters · filed 2013-02-22
2011-03-31$613.20M
10-Q · filed 2012-04-25
$155.80M
derived: sum of 2 quarters · filed 2013-02-22
$374.10M
derived: sum of 3 quarters · filed 2013-02-22
-$1.12B
derived: sum of 4 quarters · filed 2013-02-22
2010-12-31-$457.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22
-$239.10M
derived: sum of 2 quarters · filed 2013-02-22
-$1.74B
derived: sum of 3 quarters · filed 2013-02-22
-$3.03B
10-K · filed 2013-02-22
2010-09-30$218.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-26
-$1.28B
derived: sum of 2 quarters · filed 2011-10-26
-$2.57B
10-Q · filed 2011-10-26
$404.00M
derived: sum of 4 quarters · filed 2012-02-22
2010-06-30-$1.50B
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-27
-$2.79B
10-Q · filed 2011-07-27
$185.70M
derived: sum of 3 quarters · filed 2012-02-22
$303.30M
derived: sum of 4 quarters · filed 2012-02-22
2010-03-31-$1.29B
10-Q · filed 2011-04-27
$1.68B
derived: sum of 2 quarters · filed 2012-02-22
$1.80B
derived: sum of 3 quarters · filed 2012-02-22
$1.15B
derived: sum of 4 quarters · filed 2012-02-22
2009-12-31$2.97B
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22
$3.09B
derived: sum of 2 quarters · filed 2012-02-22
$2.44B
derived: sum of 3 quarters · filed 2012-02-22
$2.63B
10-K · filed 2012-02-22
2009-09-30$117.60M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-03
-$535.90M
derived: sum of 2 quarters · filed 2010-11-03
-$341.70M
10-Q · filed 2010-11-03
-$428.40M
derived: sum of 4 quarters · filed 2011-02-17
2009-06-30-$653.50M
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2010-08-03
-$459.30M
10-Q/A · filed 2010-08-03
-$546.00M
derived: sum of 3 quarters · filed 2011-02-17
-$549.20M
derived: sum of 4 quarters · filed 2011-02-17
2009-03-31$194.20M
10-Q · filed 2010-04-28
$107.50M
derived: sum of 2 quarters · filed 2011-02-17
$104.30M
derived: sum of 3 quarters · filed 2011-02-17
2008-12-31-$86.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-17
-$89.90M
derived: sum of 2 quarters · filed 2011-02-17
-$584.00M
10-K · filed 2011-02-17
2008-09-30-$3.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-28
-$497.30M
10-Q · filed 2009-10-28
2008-06-30-$494.10M
10-Q · filed 2009-07-29
2007-12-31$165.80M
10-K · filed 2010-02-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cigna Group (CI)United States$70.160B10.44
HUMANA INC (HUM)United States$45.651B18.44
CENTENE CORP (CNC)United States$30.588B-6.22
MOLINA HEALTHCARE, INC. (MOH)United States$10.091B-1,697.50
Alignment Healthcare, Inc. (ALHC)United States$1.593B121.28
TRUPANION, INC. (TRUP)United States$0.984B
UNITEDHEALTH GROUP INC (UNH)United States$336.652B26.62